These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6604250)

  • 1. [Antibody-mediated cytotoxic activity off circulating lymphocytes directed against human red blood cells in type I and type II diabetes].
    Fövényi J; Garam T; Tótpál K; Thaisz E; Bakács T
    Orv Hetil; 1983 Jun; 124(26):1547-9. PubMed ID: 6604250
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific cellular immunity in type I and type II diabetes.
    Fövenyi J; Tótpál K; Thaisz E; Garam T
    Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
    Spooren PF; Vermes I; Soons JW
    Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo.
    Schirrmann T; Pecher G
    Cancer Gene Ther; 2002 Apr; 9(4):390-8. PubMed ID: 11960290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific.
    Takahashi K; Honeyman MC; Harrison LC
    Clin Immunol; 2001 Jun; 99(3):360-4. PubMed ID: 11358432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunity in diabetes mellitus].
    Barañao RI; Rumi LS
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):7-11. PubMed ID: 6083584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunoglobulins and insulin-binding capacity of T lymphocytes in diabetes mellitus types I and II].
    Antsiferov MB; Arbuzova MI; Perelygina AA; Starosel'tseva LK
    Sov Med; 1986; (7):25-8. PubMed ID: 3489999
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional analysis of peripheral blood lymphocytes from healthy volunteers.
    Donnerstag B; Oltrogge JB; Henzel K; Rüenauver A; Baum RP
    J Clin Lab Immunol; 1993; 40(2):91-5. PubMed ID: 7932632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NKT cells in the digestive system. II. NKT cells and diabetes.
    Wu L; Van Kaer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G919-22. PubMed ID: 17600041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukocyte migration inhibition and antibody levels in diabetes mellitus].
    Rózsás Z; Horváth M; Karádi I; Bretán M
    Orv Hetil; 1981 Aug; 122(35):2157-9. PubMed ID: 7301376
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.
    Fox RI; Fong S; Tsoukas C; Vaughan JH
    J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.